Yue Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yue Huang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Changwen Zhang
Department of Urology, Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University
1 shared publication - Jianxi Shi
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publication - Xun Liu
Tianjin Institute of Urology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China
1 shared publication - Zhaopeng Li
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publication - Zhihong Zhang
Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China
1 shared publication
Latest Publications
- Open Access
- 29 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4995
The Present and Future of Artificial Intelligence in Urological Cancer
Artificial intelligence has drawn more and more attention for both research and application in the field of medicine. It has considerable potential for urological cancer detection, therapy, and prognosis prediction due to its ability to choose features in data to complete a particular task autonomously. Although the clinical application of AI is still immature and faces drawbacks such as insufficient data and a lack of prospective clinical trials, AI will play an essential role in individualization and the whole management of cancers as research progresses. In this review, we summarize the applications and studies of AI in major urological cancers, including tumor diagnosis, treatment, and prognosis prediction. Moreover, we discuss the current challenges and future applications of AI.
- 29 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (15) , 4995
Open AccessThe Present and Future of Artificial Intelligence in Urological Cancer
Artificial intelligence has drawn more and more attention for both research and application in the field of medicine. It has considerable potential for urological cancer detection, therapy, and prognosis prediction due to its ability to choose features in data to complete a particular task autonomously. Although the clinical application of AI is still immature and faces drawbacks such as insufficient data and a lack of prospective clinical trials, AI will play an essential role in individualization and the whole management of cancers as research progresses. In this review, we summarize the applications and studies of AI in major urological cancers, including tumor diagnosis, treatment, and prognosis prediction. Moreover, we discuss the current challenges and future applications of AI.